Glowpedia
Group

Neopharm Co., Ltd.

4 brands · founded 2000 · South Korea

Neopharm Co., Ltd. is a South Korean dermo-cosmetics company that develops and sells skincare aimed at sensitive and dry skin. It was founded on 1 July 2000 and is headquartered in Daejeon [1][4]. Rather than a holding company, the group is an operating manufacturer that owns and runs its own portfolio of skin-barrier brands.

The company's work centres on skin-barrier care built around a proprietary ceramide technology it calls Multi-Lamellar Emulsion (MLE). Neopharm describes this as an exclusive method that helps form a lasting protective barrier for dry and sensitive skin [2]. Its shares trade publicly on the KOSDAQ market under ticker 092730 [4].

History & milestones

Neopharm was established in 2000 as a South Korean skincare manufacturer based in Daejeon [1]. Its founding product line, ATOPALM, was positioned as a non-steroid option for sensitive and dry skin, and the MLE ceramide platform became the technical foundation the group would extend across later brands [2]. The company later listed on the KOSDAQ exchange, and it continues to manufacture and sell skincare products in South Korea [1][4].

Portfolio & brands

Neopharm operates a portfolio of dermo-cosmetic and body-care brands rather than a single label. According to a company profile, its brands include ATOPALM, a non-steroid range for sensitive and dry skin; Real Barrier, a dermo-cosmetic skincare line; Zeroid, aimed at sensitive, dry, oily or trouble-prone skin; Derma:B, sold as body moisturizers; Mission Athletecare, a sport-care line; and dermArtlogy, described as a one-to-one consulting cosmetic brand [4].

ATOPALM is the group's founding and best-known brand, and Neopharm presents it as the original expression of its MLE barrier technology [2]. The company's brand navigation also lists Derma:B among its own labels [3].

Ownership

Neopharm is a publicly listed company. Its stock trades on the KOSDAQ market under the code 092730 [4], and the company states it is listed on that exchange [1]. It remains an independent operating business focused on the manufacture and sale of skincare.

References

Sources

T1 primary · T2 secondary · T3 note
  1. [1]T1neopharm.co.kr/en/company/about.doneopharm.co.kr (company)
  2. [2]T1neopharm.co.kr/en/brand/brand_atopalm.doneopharm.co.kr (company)
  3. [3]T1neopharm.co.kr/en/brand/brand_dermab.doneopharm.co.kr (company)
  4. [4]T3stockanalysis.com/quote/kosdaq/092730/company/stockanalysis.com
Neopharm Co., Ltd. — group · Glowpedia